News Chart Perspective Therapeutics, Inc.

Stocks

CATX

US46489V3024

Biotechnology & Medical Research

Market Closed - NYSE 07:00:00 20/10/26 am AEDT			5-day change	1st Jan Change
2.190 ^USD	+0.92%		-13.10%	-20.36%

09/10	Perspective Therapeutics, Inc. Receives Fast Track Designation for PSV359 for Treatment of Adult Patients with Locally Advanced Unresectable And/Or Metastatic FAP-Positive Solitary Fibrous Tumors	CI
08/10	Perspective's Cancer Therapy Candidate Receives FDA Fast Track Designation; Shares Rise Pre-Bell	MT

94b402ae971a199d93b1eea8b7627b20.v_-2PF1CygKsRwfwIgObo72-3Hr8XC188OD3EVyqTMk._NLCWBIImnXJJkLBEDbI5I7RpjzNKHJKw7i1eB3lFIvNlflNESWrcPseSg~0173067d71c8fa0fdaf56adefd67c254